Cargando…

AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors

BACKGROUND: Brachytherapy (BT) was the first radiotherapeutic technique used to treat human disease and remains an essential modality in radiation oncology. A decline in the utilization of BT as a treatment modality has been observed and reported, which may impact training opportunities for medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Aima, Manik, Simiele, Samantha J., Richardson, Susan L., Melhus, Christopher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924109/
https://www.ncbi.nlm.nih.gov/pubmed/36651371
http://dx.doi.org/10.1002/acm2.13859
_version_ 1784887827019857920
author Aima, Manik
Simiele, Samantha J.
Richardson, Susan L.
Melhus, Christopher S.
author_facet Aima, Manik
Simiele, Samantha J.
Richardson, Susan L.
Melhus, Christopher S.
author_sort Aima, Manik
collection PubMed
description BACKGROUND: Brachytherapy (BT) was the first radiotherapeutic technique used to treat human disease and remains an essential modality in radiation oncology. A decline in the utilization of BT as a treatment modality has been observed and reported, which may impact training opportunities for medical physics residents. A survey of therapeutic medical physics residency program directors was performed as part of an assessment of the current state of BT training during residency. METHODS: In March 2021, a survey consisting of 23 questions was designed by a working unit of the Brachytherapy Subcommittee of the American Association of Physicists in Medicine (AAPM) and approved for distribution by the Executive Committee of the AAPM. The survey was distributed to the directors of the Commission on Accreditation of Medical Physics Education Programs (CAMPEP)‐accredited therapeutic medical physics residency programs by the AAPM. The participant response was recorded anonymously in an online platform and then analyzed using MATLAB and Microsoft Excel software. RESULTS: The survey was distributed to the program directors of 110 residency programs. Over the course of 6 weeks, 72 directors accessed the survey online, and 55 fully completed the survey. Individual responses from the directors (including partial submissions) were evaluated and analyzed. Nearly all participating programs (98%) utilize high dose rate BT treatments with 74% using low dose rate BT techniques. All programs treated gynecological sites using BT, and the next most common treatment sites were prostate (80%) and breast (53%). Overall, the residency program directors had a positive outlook toward BT as a radiotherapeutic treatment modality. Caseload and time limitations were identified as primary barriers to BT training by some programs. CONCLUSIONS: Based on the responses of the program directors, it was identified that the residency programs might benefit from additional resources such as virtual BT training, interinstitutional collaborations as well as resident fellowships. Programs might also benefit from additional guidance related to BT‐specific training requirements to help program directors attest Authorized Medical Physicist eligibility for graduating residents.
format Online
Article
Text
id pubmed-9924109
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99241092023-02-14 AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors Aima, Manik Simiele, Samantha J. Richardson, Susan L. Melhus, Christopher S. J Appl Clin Med Phys AAPM Reports & Documents BACKGROUND: Brachytherapy (BT) was the first radiotherapeutic technique used to treat human disease and remains an essential modality in radiation oncology. A decline in the utilization of BT as a treatment modality has been observed and reported, which may impact training opportunities for medical physics residents. A survey of therapeutic medical physics residency program directors was performed as part of an assessment of the current state of BT training during residency. METHODS: In March 2021, a survey consisting of 23 questions was designed by a working unit of the Brachytherapy Subcommittee of the American Association of Physicists in Medicine (AAPM) and approved for distribution by the Executive Committee of the AAPM. The survey was distributed to the directors of the Commission on Accreditation of Medical Physics Education Programs (CAMPEP)‐accredited therapeutic medical physics residency programs by the AAPM. The participant response was recorded anonymously in an online platform and then analyzed using MATLAB and Microsoft Excel software. RESULTS: The survey was distributed to the program directors of 110 residency programs. Over the course of 6 weeks, 72 directors accessed the survey online, and 55 fully completed the survey. Individual responses from the directors (including partial submissions) were evaluated and analyzed. Nearly all participating programs (98%) utilize high dose rate BT treatments with 74% using low dose rate BT techniques. All programs treated gynecological sites using BT, and the next most common treatment sites were prostate (80%) and breast (53%). Overall, the residency program directors had a positive outlook toward BT as a radiotherapeutic treatment modality. Caseload and time limitations were identified as primary barriers to BT training by some programs. CONCLUSIONS: Based on the responses of the program directors, it was identified that the residency programs might benefit from additional resources such as virtual BT training, interinstitutional collaborations as well as resident fellowships. Programs might also benefit from additional guidance related to BT‐specific training requirements to help program directors attest Authorized Medical Physicist eligibility for graduating residents. John Wiley and Sons Inc. 2023-01-18 /pmc/articles/PMC9924109/ /pubmed/36651371 http://dx.doi.org/10.1002/acm2.13859 Text en © 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle AAPM Reports & Documents
Aima, Manik
Simiele, Samantha J.
Richardson, Susan L.
Melhus, Christopher S.
AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors
title AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors
title_full AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors
title_fullStr AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors
title_full_unstemmed AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors
title_short AAPM BTSC Report 377: Physicist Brachytherapy Training in 2021—A survey of therapeutic medical physics residency program directors
title_sort aapm btsc report 377: physicist brachytherapy training in 2021—a survey of therapeutic medical physics residency program directors
topic AAPM Reports & Documents
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924109/
https://www.ncbi.nlm.nih.gov/pubmed/36651371
http://dx.doi.org/10.1002/acm2.13859
work_keys_str_mv AT aimamanik aapmbtscreport377physicistbrachytherapytrainingin2021asurveyoftherapeuticmedicalphysicsresidencyprogramdirectors
AT simielesamanthaj aapmbtscreport377physicistbrachytherapytrainingin2021asurveyoftherapeuticmedicalphysicsresidencyprogramdirectors
AT richardsonsusanl aapmbtscreport377physicistbrachytherapytrainingin2021asurveyoftherapeuticmedicalphysicsresidencyprogramdirectors
AT melhuschristophers aapmbtscreport377physicistbrachytherapytrainingin2021asurveyoftherapeuticmedicalphysicsresidencyprogramdirectors